# PediVax (vaxapp) — Handoff after Session 8: pneumo audit fixes (2026-08-11)

Session 8 of `.claude/prompts/plan-2026-08-10-aap-authority-parity-ux.md`
(the ten-session plan). Worked items 1 and 2 (P0/P1) of the Session 7 findings
queue in `docs/archive/audit-2026-08-11-pneumo-spec-vs-code.md`.

Branch: `fix/pneumo-audit-session8-p0-p1`, off `main`. Merged via PR
[#119](https://github.com/jojohuhu-git/vaxapp/pull/119) (squash), branch left
on GitHub (not deleted). Post-merge "Tests" and "Deploy to GitHub Pages"
workflow runs both green on `main` (commit `0ef68ac`). Live site spot-checked
after deploy — loads cleanly.

Baseline was 1942 passing (118 files, 0 failed, 4 todo) at session start; now
**1946 passing (118 files), 0 failed, 4 todo**, working tree clean at commit
`0ef68ac`.

## What's done (by finding ID from the audit doc)

1. **Item 1 (P0) — duplicate HSCT PCV advisory card.** `recommendations.js`
   had the "Post-HSCT — PCV re-vaccination" block written twice, back to
   back. Removed the second copy. Added a regression test asserting exactly
   1 HSCT PCV advisory entry (`src/tests/five-surface/high-risk.test.js`).
   Checked all five surfaces by code inspection: `regimens.js` and
   `ComplianceAuditTab.jsx` already de-dupe by `vk`, `ForecastTab.jsx` keys
   its lookup by `r.vk`, and `buildOptimalSchedule.js` has no HSCT entry at
   all by design — only the raw `genRecs()` array itself ever carried the
   visible duplicate. Commit `8eeab84`.

2. **Item 2 (P1) — `chronic_kidney` excluded from the IC-subset PPSV23
   follow-up gate.** Live-fetched the CDC child/adolescent pneumococcal
   special-situations notes (cdc.gov, July 2, 2025 schedule) via
   `verify-clinical-source` and confirmed: CDC splits kidney disease into
   two groups — general CKD needs no extra follow-up after one PPSV23 dose,
   but "maintenance dialysis" and "nephrotic syndrome" sit in the same
   immunocompromising group as asplenia/HIV/immunocomp, requiring a 2nd
   PPSV23 (or PCV20) dose ≥5 years after the first. vaxapp's single
   conflated `chronic_kidney` risk id never triggered this follow-up for
   either group. **Owner decision** (asked via AskUserQuestion): split into
   two risk ids rather than reclassify the whole checkbox as IC. Renamed
   `chronic_kidney` → "Chronic kidney disease (not on dialysis)" (unchanged
   behavior) and added new `chronic_kidney_dialysis` → "Kidney disease —
   dialysis or nephrotic syndrome" (added to the IC-follow-up gate in both
   `recommendations.js` and `buildOptimalSchedule.js`, and to the shared
   `PCV_HR_RISKS` list in `pcvDoses.js`). Live-verified in the running app:
   dialysis patient now shows both PCV20 and PPSV23 follow-up
   recommendations; general CKD patient correctly shows neither. Checked
   PneumoVax — it already has this exact two-group split
   (`src/data/riskFactors.js`), no PneumoVax-side change needed. Updated
   `docs/agent/clinical-rules.md` to document the split. Commit `5a98fd2`.

## What's NOT done — the remaining plan queue

- **Items 3–5 from the Session 7 audit** (deferred per the plan's own
  "if the queue runs longer than ~3 items, stop after 3" rule — items 1+2
  used the budget; these are all P2, no controversy in deferring):
  3. PCV21 (Capvaxive) missing as a brand option everywhere, despite
     vaxapp's own 18-year-olds being spec-eligible for it. Completeness
     gap, not a safety gap.
  4. **Unconfirmed** — healthy PCV15 catch-up may need a PPSV23 follow-up
     per PneumoVax's spec §B. Needs a live CDC source check
     (`verify-clinical-source`) before any code change — if it doesn't
     hold up, close with no action (a valid outcome).
  5. Dead "adult ≥19y high-risk PCV" branches in `recommendations.js:253`
     and `buildOptimalSchedule.js:119-122` — both unreachable, cosmetic
     cleanup only.
- **Session 9** — AAP baseline snapshot + authority-rule propagation to 3
  repos (vaxapp, MeningoVax, PneumoVax). Unchanged from prior handoffs.
- **Session 10** — UX review, read-only, produces a report. Builds on the
  already-approved `docs/ux-review-2026-07-03.md` §2–4 redesign.

## Why this is a good stopping point

Both P0/P1 items are merged, tested, live-verified, and deployed — a
complete, independent unit of work. Items 3–5 are all P2 with no safety
impact and no shared surface area with 1–2, so they can be picked up in any
order in a future session without re-deriving anything from this one.

## Resuming

1. `cd /Users/joannehuang/Downloads/vaxapp-main && git checkout main && git pull`
2. Run `npm test` — confirm **1946 passing / 0 failed / 4 todo** before any new work.
3. Start the dev server via `preview_start`, name `"PediVax dev server"`.
4. Read `docs/archive/audit-2026-08-11-pneumo-spec-vs-code.md` items 3–5 for
   exact file/line citations — don't re-derive them.
5. Item 4 needs `verify-clinical-source` (live CDC fetch) before any code
   change — resolve the source question first; closing with no action is
   valid if it doesn't hold up.
6. Use the `fix-queue` skill: reproduce → failing test → fix → full suite
   green → live-verify in the running app → commit per item, referencing
   the item number (3-5) from the audit doc.
7. Six-surface discipline still applies per `CLAUDE.md`.
8. `main` is protected — branch → PR → `gh pr merge --squash` (`ship`
   skill). Watch post-merge Tests + Deploy workflows go green, spot-check
   the live site.
9. Or, if the owner prefers, skip straight to Session 9 or 10 — items 3-5
   are optional cleanup, not blockers for the rest of the ten-session plan.

## Supersedes

`docs/archive/handoff-2026-08-11-pneumo-spec-audit-session7.md` — its
Session 8 queue (items 1-2) is now done; that file has been marked
superseded at its top with a pointer to this one.
